T. Rowe Price Investment Management, Inc. 13D and 13G filings for Utah Medical Products, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 10:04 am Sale | 2023-12-31 | 13G | Utah Medical Products, Inc. UTMD | T. Rowe Price Investment Management, Inc. | 269,166 7.400% | -72,750 (-21.28%) | Filing |
| 2023-02-14 12:40 pm Purchase | 2022-12-31 | 13G | Utah Medical Products, Inc. UTMD | T. Rowe Price Investment Management, Inc. | 341,916 9.400% | 341,916 (New Position) | Filing |